CDNKN2A Loss Defined
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma (NCT02202200) | Assistance Publique - Hôpitaux de Paris | 2014-05-01 |
Track CDNKN2A Loss Defined automatically
Every clearance here is in the API, with alerts when new ones post.